Browse products
Distribution on the pharmaceutical market in Poland 2011Development forecasts for 2011-2013 |
Polish version also available »
Our clients say...
“As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding.”
Development Manager, GVA Grimley
“We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis.”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales.
”
Market Analyst, Alpha Cement
“PMR provides a good service and is always open to discussion. All reports are well structured & are always on time.”
Member of the Managment Board, SCA Hygiene Products
“We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis.”
General Manager, Sanofi-Synthelabo
“Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. ”
General Manager, Sanofi-Synthelabo
“It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner.”
Business Analyst, Hilti Distribution, Russia
“PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. ”
Senior Trade and Investment Adviser, British Embassy in Warsaw
The report represents a comprehensive analysis of distribution on the pharmaceutical market in Poland, with information provided per individual distribution channel:
- Wholesale distribution
- Pharmacy distribution (with a focus on pharmacy chains)
- Online distribution
- Direct distribution
- Non-pharmacy distribution.
Excel database. Reliable data in a convenient format.
Did you know...
“The number of pharmacies that are part of pharmacy chains (of more than 5 pharmacies) have also been steadily rising in Poland.”
“Direct distribution/DTP will gain in popularity on the Polish pharmaceutical market.”
“The pharmaceutical wholesalers market in Poland is gradually consolidating.”
“The most pharmacies are located in Mazowieckie.”
“The leading parallel importers in the Polish pharmaceutical market are Delfarma, InPharm, Blau Farma and Forfarm.”
“In January 2011 Poland's largest auction portal, allego.pl, introduced online sales of pharmaceuticals.”
“In January 2011 the Polish market was home to 618 pharmaceutical wholesalers.”
The report is accompanied by the "Database of independent pharmacy chains in Poland 2011". The chains are presented by size: over 20 stores, 10-20 stores, 7-9 stores and 5-6 stores. In total, the database comprises over 70 pharmacy chains.
For each, it provides addresses of pharmacies comprising the chains by voivodship – nearly 1,000 records in total.
For each, it provides addresses of pharmacies comprising the chains by voivodship – nearly 1,000 records in total.
Why a report on this topic?
- to update of information provided in previous release
- to fill a gap on the market which lacks a document that would provide a comprehensive analysis of all segments of distribution on the pharmaceutical market
- in response to significant demand voiced for this type of information and data
Main topics discussed:
- Poland’s largest pharmaceutical wholesalers – financial results, number of warehouses, strategies
- Largest distributor-owned pharmacy chains in Poland
- Largest independent pharmacy chains
- Franchise pharmacy chains
- Pharmacy purchasing groups
- Wholesalers specialising in the non-pharmacy market
- Direct distribution
- Market impact of planned legislative changes
- Parallel imports
- Market shares of pharmaceutical wholesalers
- Storecounts of individual pharmacy chains in Poland
- Number of online pharmacies in Poland
- Wholesaler concentration on the pharmaceutical market
- Number of clients of pharmacies
- Largest wholesalers on the hospital market.
What questions does the report answer?
- How will the pharmacy distribution market develop between 2011 and 2013?
- How will the hospital distribution market develop between 2011 and 2013?
- Who are the largest wholesalers on the pharmacy market in Poland?
- Who are the largest wholesalers on the hospital market in Poland?
- How have the market shares of the five largest wholesalers changed over the last few years?
- Will the wholesale distribution market consolidate further?
- Which voivodships are home to the most pharmaceutical wholesalers?
- How many wholesalers specialise in non-pharmacy distribution?
- With how many pharmacies do the largest wholesalers cooperate in Poland?
- What are the revenues and financial results of the largest wholesalers in Poland?
- Which are the largest independent pharmacy chains in Poland?
- Which are the largest pharmacy chains in Poland affiliated with wholesalers?
- What percentage of pharmacies in Poland is part of a pharmacy chain?
- What is the impact of location on pharmacy revenues?
- Will there be more or fewer pharmacies in Poland in the near future?
- Which voivodships are the most/least densely populated with pharmacies?
- What is the financial condition of pharmacies in Poland?
- How many pharmacy chains in Poland have more than 100 outlets?
- What are the largest pharmacy franchise chains in Poland?
- Which entities plan to develop pharmacy franchise chains?
- Which are the largest pharmacy purchasing groups in Poland? How many outlets do they each have?
- How many pharmacies participate in wholesalers’ loyalty schemes?
- Which are the most popular loyalty schemes?
- How many online pharmacies are there in Poland?
- How will the planned legislative changes (e.g. implementation of a definition of mail order distribution) impact the online distribution segment?
- Which are the largest online pharmacies in Poland, by revenues / users / order number?
- What entities can commence operations in the online distribution segment?
- How many parallel import permits were issued in 2010?
- Which products are the most often the subject of parallel imports?
- Who are the largest parallel importers?
- Which wholesalers specialise in pharmacy distribution on the non-pharmacy market?
Report strengths
- comprehensive analysis of all distribution channels
- identification of the largest pharmacy chains and their pharmacy counts
- large library of company profiles, including info on financial performance
- analysis of the market impact of planned legislative changes
- Excel database of independent pharmacy chains
- one of a kind report available on the market.
When will the report prove useful?
- Anyone operating on the Polish pharmaceutical market
- Anyone considering entering the Polish pharmaceutical market
- Anyone planning their corporate strategy
- Anyone analysing market competition
- Anyone investigating Polish market’s investment potential
- Anyone gauging the opportunities for acquisition on the Polish market.
Who is this report for?
- Pharma companies
- Logistics firms
- Pharmacy chains – domestic and foreign
- Pharmaceutical distributors (wholesalers) – domestic and foreign
- Foreign firms investing in the Polish pharmaceutical sector
- Consulting, research and analysis firms
- Government institutions, embassies
- Chambers of commerce, industry bodies
- Universities, academic institutions
- Financial institutions (banks, brokerage houses, investment funds)
Extract from this report
- Until 2009 the pharmacy count in Poland grew rapidly (increasing 50% between 2000 and 2009). In H1 2009 this pace slowed, and for the past six months the number of pharmacies in Poland has fallen for the first time. The downtrend slowed only in the period March-May 2010.
- Given the number of residents proportionately falling on one pharmacy outlet, the lowest saturation of pharmacies can be noted in the voivodships of Warminsko-Mazurskie, Kujawsko-Pomorskie and Zachodniopomorskie, where a single pharmacy proportionately attends to 3,187, 2,911 and 2,895 inhabitants, respectively.
Market commentary by expert
The year 2010 was one of change for pharmacies and pharmacy wholesalers. Especially the wholesale segment was subject to a trend of pharmaceutical wholesalers looking to diversify their business profiles. For example, Neuca and ACP Pharma launched shared services centres and also began to establish franchise chains of pharmacies. Neuca also invested in drug manufacturing via Synoptis Pharma. At the same time, the national pharmacy count stopped to decline, and more and more outlets joined up pharmacy chains, purchasing groups and loyalty schemes. Today, all entities active on the market are getting ready to operate in a new reality created by the entry into force of the Reimbursement Act, which brings several implications for entities operating in the pharmaceuticals distribution segment.Agnieszka Stawarska, Pharmaceutical market analyst
Request sample pages/interactive screenshare
-
Report methodology p. 11
-
Executive summary p. 15
-
Pharmacy distribution p. 23
- Development forceasts for pharmacy segment for 2011-2013 p. 23
-
Wholesale distribution p. 24
-
Key events and trends p. 24
- Selected events and trends in 2009-2011 p. 24
- Expected events and trends in 2011-2013 p. 25
- Number and types of wholesalers p. 26
- Concentration of wholesalers on the pharmacy market p. 28
- Largest players on the pharmacy market p. 29
-
Full-line distribution p. 30
- Overview of the model p. 30
- Profiles of selected leading players p. 31
-
Short-line distribution p. 66
- Overview of the model p. 66
- Profiles of selected leading players p. 67
-
Key events and trends p. 24
-
Pharmacy distribution p. 69
-
Key events and trends p. 69
- Selected events and trends in 2009-2011 p. 69
- Expected events and trends in 2011-2013 p. 70
- Number of pharmacy outlets p. 71
- Location of pharmacies p. 74
- Financial standing of pharmacies p. 75
- Pharmacy cooperation with wholesalers p. 79
-
Pharmacy chains p. 79
- Percentage of pharmacies belonging to pharmacy chains p. 79
-
The number of pharmacies belonging to pharmacy chains p. 80
- 5-15 pharmacies p. 82
- 16-30 pharmacies p. 83
- 31-100 pharmacies p. 83
- Over 100 pharmacies p. 84
-
Pharmacy chains with connections to wholesalers p. 84
- Profiles of selected leading players p. 85
-
Independent pharmacy chains p. 94
-
Pharmacy chains of over 20 outlets p. 94
- Profiles of selected leading players p. 94
-
Pharmacy chains numbering p. 10-20 outlets p. 99
- Profiles of selected leading players p. 99
-
Pharmacy chains of fewer than 10 outlets p. 108
- Profiles of selected leading players p. 109
-
Pharmacy chains of over 20 outlets p. 94
- Franchise pharmacy chains p. 113
- Pharmacy buying groups p. 115
- Loyalty programmes p. 116
- Pharmacy points p. 117
-
Online pharmacies p. 118
- Overview of the segment p. 118
-
Key developments and trends p. 118
- Selected developments and trends in 2009-2011 p. 118
- Expected developments and trends in 2011-2013 p. 120
- Number of online pharmacies p. 121
-
Consumer behaviours p. 124
- Internet users p. 124
- Persons buying medicines from online pharmacies, by age p. 125
- Persons buying medicines from online pharmacies, by education p. 127
- Persons buying medicines from online pharmacies, by professional status p. 127
- Persons buying medicines from online pharmacies, by income p. 128
- Persons buying medicines from online pharmacies, by place of residence p. 129
- Reasons for buying in online pharmacies p. 130
- Best-selling products available from online pharmacies p. 131
-
Leading online pharmacies p. 132
- Profiles of selected leading players p. 134
-
Key events and trends p. 69
-
Non-pharmacy distribution p. 139
-
Entities distributing drugs via a non-pharmacy channel p. 139
-
Wholesale distribution p. 140
- Profiles of selected leading players specialising in non-pharmacy distribution p. 141
-
Retail distribution p. 148
-
General stores p. 148
- Hypermarkets p. 149
- Supermarkets p. 150
- Discount stores p. 150
- Small grocery stores p. 151
- Convenience stores p. 151
- Shops at petrol stations p. 152
- Kiosks p. 152
- Cosmetic shops p. 153
-
General stores p. 148
-
Wholesale distribution p. 140
-
Entities distributing drugs via a non-pharmacy channel p. 139
-
Hospital distribution p. 155
- Development forceasts for hospital segment for 2011-2013 p. 155
- Segment profile p. 156
- Financial condition of hospitals in Poland p. 158
-
Key players on the hospital market p. 159
- Profiles of selected leading players p. 160
-
Direct, DTP and exclusive distribution p. 165
- Key features of the models p. 165
- Examples of manufacturers using direct distribution or DTP on the Polish market p. 167
-
Paralell trade p. 171
-
Parallel imports p. 171
- Number of parallel imports licences p. 171
- Size of the market p. 172
- Savings on parallel imports p. 174
-
Largest players on the parallel imports market p. 175
- Profiles of selected leading players p. 176
- Parallel exports p. 180
-
Parallel imports p. 171
-
Legal environment p. 183
-
Sale of OTC drugs at non-pharmacy outlets and pharmacy points p. 183
- Types of non-pharmacy distribution outlets p. 183
- Premises standards and staff qualification requirements p. 183
-
Number of products admitted to trading and the applicable classification criteria p. 185
- Pharmacy points p. 186
- Herbal medical stores p. 186
- General stores and specialist medical supplies stores p. 187
- Mail-order sale p. 188
- Parallel trade p. 189
- Direct distribution p. 189
-
Reimbrusement Act p. 191
- Pharmacies p. 191
- Wholesalers p. 192
- Manufacturers p. 193
- Hospitals p. 194
-
Sale of OTC drugs at non-pharmacy outlets and pharmacy points p. 183
-
List of graphs p. 195
-
List of tables p. 201
-
About PMR p. 203
-
Contact PMR p. 204
List of graphs
- Value (PLN bn) and growth in pharmacy market in Poland, 2007-2013
- Value (PLN bn) and change in hospital drug market in Poland, 2007-2013
- Value (PLN bn) and growth in pharmacy market in Poland, 2007-2013
- Location of pharmaceutical wholesalers’ warehouses in Poland, by voivodship, January 2011
- Number of pharmaceutical wholesalers’ warehouses licensed to trade in specific ranges of medicinal products in Poland, by type of product sold, January 2011
- Market shares of 10 largest wholesalers on the pharmacy market in Poland, 1994-2010
- Shares of wholesale groups in distribution to pharmacies in Poland, Q4 2010
- Market shares of the largest players on the pharmaceutical wholesale market in Poland, by sales to pharmacies, Q4 2010
- Full-line distribution model in Poland, 2011
- Vote structure at the GSM of Neuca, 2011
- Neuca group’s sale revenues (PLN m) and their change in Poland, 2003-2011
- Sales structure of the Neuca group, by subsidiary undertaking, Q1-Q3 2010
- Neuca group’s net profit (PLN m) and its change in Poland, 2003-2011
- Vote structure at PGF’s GSM, 2011
- Business structure of the PGF group, 2011
- The PGF group’s wholesale logistics structure in Poland, 2011
- PGF group’s sale revenues (PLN m) and their change in Poland, 2001-2010
- PGF group’s net profit (PLN m) and its change in Poland, 2001-2010
- Sales structure of the PGF group, by type of activity, 2010
- Vote structure at Farmacol’s GSM, 2011
- The Farmacol group’s wholesale logistics structure in Poland, 2011
- Farmacol group’s sale revenues (PLN m) and their change in Poland, 2004-2010
- Revenue and net profit/loss of Cefarm companies comprising the Farmacol group in Poland (PLN m), 2009
- Farmacol group’s net profit (PLN m) and its change in Poland, 2004-2010
- Cefarm Bialystok’s revenue and net profit/loss in Poland (PLN m), 2004-2009
- Mediq group structure, 2011
- ACP Pharma wholesale logistics structure in Poland, 2011
- ACP Pharma’s wholesale revenues (PLN m) and their change in Poland, 2005-2010
- ACP Pharma’s sales structure in Poland, 2010
- Slawex wholesale logistics structure in Poland, 2011
- Phoenix Pharma wholesale logistics structure in Poland, 2011
- Phoenix Pharma’s group’s sale revenues (PLN m) and their change in Poland, 2004/2005-2009/2010
- Phoenix Pharma’s net profit/loss (PLN m) and its change in Poland, 2004/2005-2009/2010
- Hurtap wholesale logistics structure in Poland, 2011
- Hurtap’s sale revenues (PLN m) and their change in Poland, 2003-2009
- Hurtap’s net profit (PLN m) and its change in Poland, 2003-2009
- Multi Pharme’s sale revenues and net profit in Poland (PLN m), 2004-2009
- Intra’s sale revenues (PLN m) and their change in Poland, 2003-2008
- Intra’s net profit (PLN m) and its change in Poland, 2003-2008
- Medicare’s sale revenues (PLN m) and their change in Poland, 2003-2009
- Medicare’s net profit (PLN m) and its change in Poland, 2003-2009
- Lubfarm’s revenues (PLN m) and their change in Poland, 2003-2009
- Lubfarm’s net profit (PLN m) and its change in Poland, 2003-2009
- Preska’s sale revenues (PLN m) and their change in Poland, 2003-2007 and 2009
- Preska’s net profit/loss (PLN ‘000) in Poland, 2003-2007 and 2009
- Salus International’s sale revenues (PLN m) and their change in Poland, 2002-2009
- Salus International’s net profit (PLN m) and its change in Poland, 2002-2009
- Short-line distribution model in Poland, 2011
- Pretium Farm’s sale revenues (PLN m) and their change in Poland, 2006-Q3 2010
- The number of patients visiting the average pharmacy in Poland, per year and per month, 2007-2010
- Number of pharmacy outlets in Poland, by type, March 2011
- Number of pharmacy outlets in Poland, by voivodship, March 2011
- Number of residents per pharmacy outlet in Poland, by voivodship, March 2011
- Pharmacies in Poland (%), by location, August 2007 and August 2010
- Pharmacies in Poland (%), by location, 2010
- Average monthly turnover of pharmacies (PLN ‘000) and its change in Poland, January-December 2010
- Average monthly revenue per pharmacy in Poland (PLN ‘000), by location, 2007-2010
- Share of pharmacies located in individual locations in total revenue generated by the pharmacy market in Poland, January-August 2010
- Turnover on the sale of OTC products in individual pharmacy locations compared to the average pharmacy turnover in Poland (%), 2010
- Average annual sales of OTC medicines by pharmacies in Poland (PLN ‘000): loyalty programme pharmacies, private pharmacies and chain pharmacies, 2009-2010
- Percentage of pharmacies belonging to pharmacy chains in Poland, selected years and quarters, 2005-Q3 2010
- Number of pharmacies belonging to pharmacy chains in Poland, by chain size, Q3 2010
- Percentage of pharmacies owned by pharmacy chains in Poland, by owner, Q3 2010
- Number of pharmacy chains of 5 to 15 outlets and number of pharmacies in chains in Poland, Q3 2005 and Q3 2009-Q3 2010
- Number of pharmacy chains of 16 to 30 outlets and number of pharmacies in chains in Poland, Q3 2005 and Q3 2009-Q3 2010
- Number of pharmacy chains of 31 to 100 outlets and number of pharmacies in chains in Poland, Q3 2005-Q3 2010
- Number of pharmacy chains of over 100 outlets and number of pharmacies in chains in Poland, Q3 2005-Q3 2010
- Selected largest pharmacy chains operated by pharmaceutical wholesalers in Poland, 2010
- CEPD holding structure, 2011
- Structure of the pharmacy chain managed by CEPD in Poland, 2010
- Pharmacies belonging to Farmacol in Poland, by name, March 2011
- ACP Pharma retail sale revenues in Poland (PLN m) and their dynamics (%), 2005-2010
- Selected largest independent pharmacy chains in Poland (no. of outlets), with over 20 outlets, March 2011
- Revenues and net profit/loss of BRL Center in Poland (PLN m), 2004-2009
- Revenues and net profit/loss of Euro Apteka in Poland (PLN m), 2003-2009
- Revenues and net profit of Apteki Kwiaty Polskie in Poland (PLN m), 2004-2009
- Revenues and net profit/loss of Super-Pharm in Poland (PLN m), 2004-2010
- Selected largest independent pharmacy chains in Poland (no. of outlets),20 outlets, March 2011
- Revenues and net profit of Ziko in Poland (PLN m), 2005-2009
- Revenues and net profit of Farmexim in Poland (PLN m), 2004-2009
- Revenues and net profit of Dr Zdrowie in Poland (PLN m), 2004-2009
- Pharmacies in the Bonis Avibus chain (no. of outlets by proprietor) in Poland, March 2011
- Revenues generated by Pama Farm and Gardos in Poland (PLN m), 2007-2009
- Revenues and net profit of GWM in Poland (PLN m), 2003-2009
- Revenues and net profit of Dolnoslaska Grupa Apteczna in Poland (PLN m), 2004-2009
- Revenues and net profit of Medicus in Poland (PLN m), 2004-2009
- Pharmacies owned by the Burchacinski family in Poland, March 2011
- Revenues and net profit of Burchacinscy sp. j. in Poland (PLN m), 2008-2009
- Selected largest independent pharmacy chains in Poland (no. of outlets),9 outlets, March 2011
- Selected largest independent pharmacy chains in Poland (no. of outlets),6 outlets, March 2011
- Revenue generated by Olimpijska WAC and AB Initio in Poland (PLN m), 2008-2009
- Revenues and net profit of Corda in Poland (PLN m), 2005-2009
- Pharmacies owned by Maria Wojtanowska-Rzytki in Poland, March 2011
- Revenues and net profit of Apteka Ligocka in Poland (PLN m), 2007-2009
- Revenues and net profit/loss of Tak-Tik in Poland (PLN m), 2003-2009
- Revenues of Apteki Zywczyk and Lekpol in Poland (PLN m), 2006-2009
- Percentage of pharmacies participating in franchise programmes in Poland, Q3 2010
- Percentage of pharmacies in formal buying groups in Poland, Q3 2010
- Percentage of pharmacies participating in loyalty programmes in Poland, Q3 2010
- Categories of shopping raising greatest concerns of internet users in Poland, September 2010
- Percentage of persons using the internet in Poland, by age, 2009
- Percentage of internet users in Poland compared to selected European countries, January 2011
- The percentage of persons buying OTC drugs through the internet in Poland, by age, 2009
- Customers of online pharmacies in Poland, by age, 2009
- The percentage of persons buying OTC drugs through the internet in Poland, by education, 2009
- The percentage of persons buying OTC drugs through the internet in Poland, by professional status, 2009
- The percentage of persons buying OTC drugs through the internet in Poland, by income, 2009
- The percentage of persons buying OTC drugs through the internet in Poland, by place of residence, 2009
- Persons buying medicines from online pharmacies in Poland, by place of residence, 2009
- Persons for whom Poles buy goods online in Poland, 2009
- Reasons for shopping in online pharmacies in Poland (%), 2010
- Most popular medicines and dietary supplements sought in internet pharmacies in Poland, May 2010
- Best-selling product categories available from online pharmacies in Poland, 2010
- The most popular online pharmacies in Poland, by number of users (real users in ‘000), December 2010
- The most popular online pharmacies in Poland, by internet user reach (%), December 2010
- Sales revenue and net profit/(loss) of DomZdrowia.pl in Poland (PLN ‘000), 2007-2010
- Non-pharmacy distribution model in Poland, 2011
- Dargo-Trade pharmaceutical wholesale distribution structure in Poland, March 2011
- Eko-Era pharmaceutical wholesale distribution structure in Poland, March 2011
- KDWT pharmaceutical wholesale distribution structure in Poland, March 2011
- Lekkerland pharmaceutical wholesale distribution structure in Poland, March 2011
- Polski Tyton pharmaceutical wholesale distribution structure in Poland, March 2011
- Ruch pharmaceutical wholesale distribution structure in Poland, March 2011
- Shares of various retail formats in the grocery market in Poland, by value, 2009
- Number of petrol stations owned by the major fuel concerns in Poland, H1 2010
- Estimated number of kiosks in the chains of the largest press distributors in Poland, March 2011
- Selected largest cosmetic shop chains in Poland (no. of stores), March 2011
- Value (PLN bn) and change in hospital drug market in Poland, 2007-2013
- Drug distribution model on the hospital market in Poland, 2011
- Total debt of independent healthcare centres in Poland (PLN bn), Q1 2007-Q4 2010
- Debt due from independent public healthcare centres in Poland (PLN bn), Q1 2007-Q4 2010
- Sales to hospitals compared to total sale revenues of PGF (PLN m) in Poland, 2007-2010
- PGF Urtica’s revenue in Poland (PLN m), 2001-2010
- Revenues and net profit of Hand-Prod in Poland (PLN m), 2008-Q3 2010
- Revenues and net profit of Asclepios in Poland (PLN m), 2006-2009
- Direct-to-pharmacy distribution model in Poland, 2011
- Direct distribution model in Poland, 2011
- Number of parallel imports licences issued in Poland, 2004-January 2011
- Parallel imports of medicines into Poland, by number of licences, 2010
- Value of parallel imports of medicines into Poland (PLN m), 2006-2010
- Number of packs of parallel imported medicines sold in Poland (m), Q1-Q3 2009 – Q1-Q3 2010
- Savings to patients, hospitals and NFZ achieved as a result of the launch of parallel imports of medicines (PLN m), November 2005-December 2009
- Polish market of parallel importers, by number of permits, 2010
- Delfarma’s revenues and net profit (PLN m) in Poland, 2005-2009
- Revenues and net profit (PLN m) of InPharm in Poland, 2008-May 2009
- Revenues and net profit (PLN m) of Blau Farma in Poland, 2004-2008
- Revenues and net profit (PLN m) of Forfarm in Poland, 2007-2008
- Average unit price of medicines (€) in Poland in comparison to other European countries, Q2 2009-Q1 2010
- Possible changes in the business model of pharmaceutical companies as a result of the Reimbursement Act coming into force in Poland, 2012
List of tables
- Comparison of the properties of wholesale service on the pharmaceutical distribution market in Poland, 1990s, 2000 and 2010
- Key data concerning the Neuca group in Poland, March 2011
- Acquisitions by Torfarm/Neuca in the wholesale segment in Poland, 2007-2009
- Key data concerning the PGF group in Poland, March 2011
- Takeovers by PGF in the wholesale segment, 2007-2009
- Key data concerning the Farmacol group in Poland, March 2011
- Takeovers by Farmacol in the wholesale segment in Poland, 2008-2009
- Key data concerning ACP Pharma in Poland, March 2011
- Key data concerning Phoenix Pharma in Poland, March 2011
- Key data concerning Salus International in Poland, March 2011
- Percentage of pharmacies participating in chains, loyalty programmes and buying groups in Poland, Q3 2010
- Selected acquisitions of pharmacies executed by PGF in Poland, 2007-2008
- Revenue and net profit (loss) of selected pharmacies and pharmacy chains held by PZF Cefarm Lublin in Poland, 2008-2009
- Revenue and net profit (loss) of selected pharmacies and pharmacy chains held by Apteki Cefarm Sp. z o.o. in Poland, 2008-2009
- Revenue and net profit (loss) of selected pharmacies and pharmacy chains held by Apteki Polskie in Poland, 2008-2009
- Revenue and net profit (loss) of selected pharmacies and pharmacy chains held by Apexim in Poland, 2008-2009
- Revenue and net profit (loss) of selected pharmacies and pharmacy chains held by Cefarm Slaski in Poland, 2008-2009
- Revenue and net profit (loss) of selected pharmacies and pharmacy chains held by Cefarm Rzeszow in Poland, 2008-2009
- Revenue and net profit (loss) of selected pharmacies and pharmacy chains held by Cefarm Zielona Gora in Poland, 2008-2009
- Revenue and net profit/loss of selected members of the GWM group in Poland, 2008-2009
- Selected formal buying groups of pharmacies in Poland and the number of pharmacies in the groups, March 2011
- Selected loyalty programmes run by wholesalers in Poland and the number of pharmacies participating in the programmes, 2010
- Online pharmacies operating in Poland, March 2011
- Revenue, number of orders and number of users of selected leading online pharmacies in Poland, 2008-2009
- Selected marketing campaigns run by DomZdrowia.pl in cooperation with medicine manufacturers
- Hypermarket chains in Poland by value of sales and number of outlets, 2008 and 2009
- Largest supermarket chains in Poland by value of sales and number of outlets, 2008 and 2009
- Discount chains in Poland by value of sales and number of outlets, 2008 and 2009
- Largest chains of small grocery stores in Poland by value of sales and number of outlets, 2008 and 2009
- Largest convenience store chains in Poland, by value of sales and number of stores, 2008 and 2009
- Manufacturers and countries of origin of medicines imported to Poland by Delfarma as parallel imports, 2006-2010
- Manufacturers and countries of origin of medicines imported to Poland by InPharm as parallel imports, 2006-2010
- Manufacturers and countries of origin of medicines imported to Poland by Blau Farma as parallel imports, 2006-2010
- Manufacturers and countries of origin of medicines imported to Poland by Forfarm as parallel imports, 2006-2010
- Comparison of premises standards and staff qualification requirements applying to the sale of medicinal products by herbal medical stores, general stores/specialist medical supplies stores and pharmacy points in Poland, 2011
- Comparison of staff qualification requirements dispensing medicinal products at herbal medical stores, general stores/specialist medical supplies stores and pharmacy points in Poland, 2011
- The number and criteria of medicinal products approved for sale at pharmacy points, herbal medical outlets, general stores and specialist medical supplies stores in Poland, 2011
- Comparison of the wording of the Pharmaceutical Law and Directive 2001/83/EC in the area of fulfilling supply obligations
- Key proposed changes in the Reimbursement Act in Poland, 2011
ACP Pharma
Apteka Dyżurna
Apteka Pod Różą
AstraZeneca
Blau Farma
Cefarm24.pl
Delfarma
Doz.pl
Dr. Max
Euro-Apteka
Farmacol
Forfarm
GlaxoSmithKline
InPharm
Neuca
Novartis
OPDF
PGF
PGF Urtica
Pretium Farm
Salus International
Sanofi-Aventis
Slawex
Super-Pharm
and more...
Apteka Dyżurna
Apteka Pod Różą
AstraZeneca
Blau Farma
Cefarm24.pl
Delfarma
Doz.pl
Dr. Max
Euro-Apteka
Farmacol
Forfarm
GlaxoSmithKline
InPharm
Neuca
Novartis
OPDF
PGF
PGF Urtica
Pretium Farm
Salus International
Sanofi-Aventis
Slawex
Super-Pharm
and more...
Distribution on the pharmaceutical market in Poland 2011
Development forecasts for 2011-2013
Choose your version of this product:
| Language / Licence | Single | 5 Users | Corporate | Global |
| English or Polish | 1800€ | 2700€ | 3600€ | 4500€ |
| English and Polish | 2520€ | 3780€ | 5040€ | 6300€ |
Compare licences
- - for the product preservation: saving the product in the memory of one computer belonging to the client;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.